A very important question in immunology is to determine which factors decide whether an immune response can e¤ciently clear or control a viral infection, and under what circumstances we observe persistent viral replication and pathology. This paper summarizes how mathematical models help us gain new insights into these questions, and explores the relationship between antiviral therapy and long-term immunological control in human immunode¢ciency virus (HIV) infection. We ¢nd that cytotoxic Tlymphocyte (CTL) memory, de¢ned as antigen-independent persistence of CTL precursors, is necessary for the CTL response to clear an infection. The presence of such a memory response is associated with the coexistence of many CTL clones directed against multiple epitopes. If CTL memory is ine¤cient, then persistent replication can be established. This outcome is associated with a narrow CTL response directed against only one or a few viral epitopes. If the virus replicates persistently, occurrence of pathology depends on the level of virus load at equilibrium, and this can be determined by the overall e¤cacy of the CTL response. Mathematical models suggest that controlled replication is re£ected by a positive correlation between CTLs and virus load. On the other hand, uncontrolled viral replication results in higher loads and the absence of a correlation between CTLs and virus load. A negative correlation between CTLs and virus load indicates that the virus actively impairs immunity, as observed with HIV. Mathematical models and experimental data suggest that HIV persistence and pathology are caused by the absence of su¤cient CTL memory. We show how mathematical models can help us devise therapy regimens that can restore CTL memory in HIV patients and result in long-term immunological control of the virus in the absence of life-long treatment.
INTRODUCTION
There is mounting experimental evidence that cytotoxic T lymphocytes (CTLs) play an important role in limiting viral replication and thus in contributing to virus control or clearance. Both in human immunode¢ciency virus (HIV) and human T-cell lymphotropic virus (HTLV) infection, the make-up of the major histocompatibility complex (MHC) class I genes correlates with set-point virus load and with the disease status of the host (Carrington et al. 1999; Je¡ery et al. 1999; Saah et al. 1998 ). In HIV-infected patients, long-term non-progression is associated with high levels of CTLs and low virus load (Harrer et al. 1996a,b; Rosenberg et al. 1997) , while depletion of CD8 T cells in simian immunode¢ciency virus (SIV)-infected macaques results in a rapid increase in viral burden (Jin et al. 1999; Schmitz et al. 1999) .
While these observations generally indicate that the presence of CTLs contributes to virus control, the qualitative properties of CTLs that are required for an e¤cient response are still unclear. In HIV infection, disease progression can occur despite the presence of CTLs. In HTLV-I infection, vigorous CTL responses are detected. Yet, the virus persists at relatively high levels. In lymphocytic choriomeningitis virus (LCMV) or hepatitis B virus infection, coexistence of virus and CTLs can result in immunopathological e¡ects and consequent death of the host. Understanding the properties of CTL-mediated virus control is not only interesting from an immunological point of view, but it is also crucial for the outcome of antiviral treatment. With viruses such as HIV, drug therapy alone has proven not to be a practical strategy for long-term prevention of disease. The long life span of some infected cells, as well as the presence of latent virus reservoirs renders eradication by drug therapy a di¤cult goal to achieve (Chun et al. 1997; Finzi et al. 1997; Perelson et al. 1996) . In addition, problems regarding compliance of patients and drug resistance limit the use of this approach (Condra et al. 1995; Larder et al. 1989; Richman 1994) . Instead, increased attention has been given to immunotherapy with the aim of achieving long-term immunological control of the infection.
The interactions between virus, target cells and the immune system are highly nonlinear. Thus, the equilibrium outcomes of an infection are frequently counterintuitive. Mathematical models take us beyond verbal or graphical reasoning and provide a solid framework upon which to build experiments and generate hypotheses. In this review we summarize recent insights gained by mathematical modelling concerning correlates of CTL-mediated virus control. These ¢ndings improve our understanding of possible mechanisms underlying virus-induced immune suppression and suggest treatment regimens that can overcome immune impairment and result in long-term control of the infection.
THE CORRELATION BETWEEN CTLs AND VIRUS LOAD
A basic immunological measure is the correlation between CTLs and virus load in persistent infections. Indeed, this measure has been used to make inferences about the role of the CTLs in controlling the virus (Ogg et al. 1998; Wodarz et al. 2000) . Among HIV-infected patients, a negative correlation between CTLs and virus load was found (Ogg et al. 1998) . This negative correlation has been interpreted as evidence for a strong CTL response controlling the infection, since high levels of CD8 T cells were associated with low virus load. However, among people infected with the related virus HTLV-I, a positive correlation was found between provirus load and speci¢c CTLs in asymptomatic carriers, while the correlation was zero in symptomatic patients (Wodarz et al. 2000) . At the same time there is genetic evidence that virus control in asymptomatic carriers is due to an e¤cient CTL response (Je¡ery et al. 1999) .
Both the data on HIV-1 and HTLV-I are in agreement with basic mathematical models of virus infections (Wodarz et al. 2000) . The models predict that e¤cient CTL-mediated virus control results in a positive correlation between virus load and CTLs in cross-sectional studies, while the correlation is zero if CTLs are ine¡ective and do not signi¢cantly limit viral replication. The positive correlation among strong CTL responders is a general principle underlying predator^prey type interactions: the more e¤cient the CTLs, the lower virus load and the weaker the stimulus to maintain high numbers of CTLs. In the light of these ¢ndings, how can the negative correlation between CTL and virus load among HIVinfected patients be explained ? Mathematical models (Wodarz et al. 2000) suggest that the negative correlation is the result of extensive virus-induced immune impairment, and not the result of e¤cient virus control. The higher the virus load, the more the virus population gains the upper hand and the fewer the number of CTLs. In this simulation the CTLp response is still relatively strong and keeps the replicating virus below the detection limit. After the virus has been controlled, an elevated number of CTLp remains due to a combination of constant antigenic stimulation and antigen-independent persistence of CTLs. Since the virus has not been cleared, the e¡ector response also persists at low levels. If the life span of CTLp in the absence of antigen is even shorter, virus load may remain above the detection limit, which in turn may lead to clinical symptoms.
PROPERTIES OF VIRUS CONTROL
that are required for e¤cient CTL-mediated control of viral replication, or virus clearance. Mathematical models have identi¢ed two parameters (Nowak & Bangham 1996; Wodarz et al. 1999) . First, the rate of CTL activation^proliferation in response to antigen (Nowak & Bangham 1996) is important for limiting virus load, and this has been shown in persistent infections such as HIV and HTLV (Carrington et al. 1999; Je¡ery et al. 1999; Saah et al. 1998) . However, in addition, virus clearance, or e¤cient long-term CTL-mediated control, also requires antigen-independent long-term persistence of memory CTL precursors (CTLp) (Wodarz et al. 1999) . If the life span of the CTLp in the absence of antigen is short, the virus can establish a persistent infection (¢gure 1). This can be understood intuitively as follows.
When the virus population declines because of CD8-mediated activity, the CTLp population also declines, which in turn reduces the immunological pressure on the virus population and enables the virus to settle at a stable equilibrium. In contrast, with antigen-independent persistence of CTLp, the CTL population reaches a stable level while virus load drops. This maintains continuous pressure on the declining virus population, and will drive the virus population to extinction (or to an extremely low equilibrium abundance). Thus, antigenindependent persistence of memory CTLp might be required for long-term virus control or clearance.
(b) Virus persistence and pathology According to the model, failure to generate e¤cient memory CTLp results in virus persistence. The level of virus load in such a scenario depends on the e¤cacy of the CTL response, or the CTL responsiveness. The weaker the CTL responsiveness, the higher the virus load and the higher the chances of developing clinical symptoms with cytopathic infections. With non-cytopathic viruses, high virus load does not result in disease (Zinkernagel 1996) . However, in this case, coexistence of CTLs and virus has been shown to result in immunopathology, de¢ned as a reduction of the overall number of target cells in the presence, compared with the absence, of CTLs (Zinkernagel 1993 (Zinkernagel , 1996 . It has been argued that with such infections, CTLs play a detrimental role and that therapy should be aimed at removing the CTL responses. Mathematical models can be used to de¢ne the conditions under which a persistent infection with a noncytopathic virus results in CTL-induced pathology (Krakauer & Nowak 1999; Wodarz & Krakauer 1999) . CTL-induced pathology occurs if the rate of viral replication is fast relative to the CTL responsiveness of the host (Wodarz & Krakauer 1999 ) (¢gure 2). In this scenario, viral replication depletes the number of uninfected cells, while the number of infected cells is limited by the CTL response. For slowly replicating viruses CTL-induced pathology will be observed if the CTL response is very weak (¢gure 2). For fast-replicating viruses, CTL-induced pathology occurs if the CTL response is weak or intermediate. The presence of an e¤cient and strong CTL response results in virus control and never in CTLinduced pathology. Hence, similar to more cytopathic viruses, pathology with non-cytopathic infections can be the result of an ine¤cient CTL response. We plot the total number of target cells (uninfected + infected) at equilibrium, in dependence of the e¤cacy of cell-mediated immunity and the replication rate of the virus. We assume that the virus is non-cytopathic. We de¢ne immunopathology by a reduction of the total number of target cells in the presence of CTLs, compared with the absence of CTLs. CTL-induced pathology is most likely to occur at a low or intermediate e¤cacy of the CTL response. In addition, the replication rate of the virus plays an important role. The faster the replication kinetics of the virus, the more severe the degree of pathology observed. If the virus replicates at a fast rate, a signi¢cant reduction in the total number of target cells will be observed even in the presence of a relatively strong CTL response. If the virus replicates slowly, any degree of immunopathology is observed only in the presence of ine¤cient CTL. Thus, for slowly replicating viruses, an increase in the CTL responsiveness is likely to bene¢t the host, while for faster replicating strains, the opposite applies (see vertical dashed line and arrows).
shown with a mathematical model taking into account multiple CTL clones directed against di¡erent epitopes of the same virus population (Wodarz & Nowak 1999a ). In such a scenario, the CTL clones are essentially in competition with each other (De Boer & Perelson 1994; Nowak et al. 1995) . Competitive ability correlates with the CTL immunogenicity of the epitope, c i . The CTL clone directed at the epitope with the largest c i is the most superior competitor. The outcome of these competitive interactions depends on the life span of the CTL response in the absence of antigen. According to equilibrium analysis, only the clone with the highest CTL immunogenicity, c i , can survive at signi¢-cant levels. Mathematically speaking, all other CD8 clones go extinct, although in practical terms, the spatial environment of the immune system could result in persistence of these clones at low levels. The reason is that the competitively superior CTL clone reduces virus load to levels too low to stimulate the weaker CTL clones. This result will be obtained if the life span of the CTLp response in the absence of antigen is short. Thus, lack of e¤cient CTLmediated control of the infection correlates with the presence of an immunodominant CTL clone (¢gure 3).
On the other hand, if the life span of the CTLp response in the absence of antigen is long, the dynamics between virus replication and the CTL response converge to a quasi-equilibrium. Virus load at the quasi-equilibrium (ŷ) has similar properties as virus load at the true equilibrium ( y ¤ ). However, it is generally higher. Now, coexistence of multiple CTL clones directed against di¡erent epitopes is possible (¢gure 3). This is because the competitively superior CTL clone does not reduce virus load down to the true equilibrium, but only to the quasi-equilibrum, where virus load may still be su¤cient to stimulate the weaker CTL clones. In summary, e¤cient long-term virus control does not lead to immunodominance, but to a broad CTL response directed against multiple epitopes. These predictions are supported by data from an HIVinfected individual who has been classi¢ed as a long-term non-progressor (Harrer et al. 1996a) . The patient had strong CTL responses, low viral load, and a stable CD4 T-cell count of 4 500 cells m l 71 15 years after infection (Harrer et al. 1996a) . The study revealed the presence of a broad CTL response directed against multiple epitopes and maintained at high levels despite the low level of viraemia (Harrer et al. 1996a,b) . This supports the prediction that broad CTL responses can result from a long life span of CTLp in the absence or at low levels of antigen. On the other hand, faster-progressin g patients are characterized by narrow CTL responses (Borrow et al. 1997; Goulder et al. 1997) . Although CTLs are present during the asymptomatic phase, these CTL seem short lived in the absence of antigen (Kalams et al. 1999b) . Starting antiretroviral therapy in these patients results ¢rst in a transient increase of CTLp, followed by a rapid decline to low levels (Kalams et al. 1999b) . The temporary increase in CTL numbers is likely to be caused by a trade-o¡ between antigenic stimulation and virus-induced immune impairment. When viral replication is stopped, the amount of immune impairment is reduced, and before virus load has signi¢cantly declined, the number of CTLs can increase. Once virus load drops to low levels the antigenic stimulus is removed. The observation that the level of CTLp then also declines indicates that many of the CTLp seen in HIV-infected patients are short lived at low levels of antigen.
Previous theoretical work (Nowak et al. 1995) suggested that lack of immunodominance can be a consequence of an antigenically heterogeneous virus population. This hypothesis was supported by data from an HIV-infected patient with a relatively low CD4 T-cell count of around 200 cells m l 71 (Nowak et al. 1995) . Hence, the presence of CTLs directed against multiple epitopes can indicate two alternative situations, depending on the level of virus load found in the patient: (i) if virus load is low, a broad CTL response results from the presence of e¤cient memory CTLs that are long lived in the absence of antigen, and have the potential to control virus replication in the longterm; and (ii) if virus load is high, the presence of CTLs directed against multiple epitopes indicates heterogeneity in the virus population caused by antigenic variation. The same study (Nowak et al. 1995 ) also suggested that a narrow CTL response indicates the presence of a homogeneous virus population and stable virus control. This hypothesis was supported by a patient with a higher CD4 T-cell count. However, although the CD4 T-cell count declined slowly in this patient, it reached about 300 cells m l 71 after about 50 months. Hence, this patient cannot be classi¢ed as a long-term non-progressor, and corresponds better to a typical progressor. We conclude that the narrow CTL response in this patient indicates that the CTLp are short lived in the absence of antigen, which in turn could be the reason for the steady loss of virus control and decline of the CD4 T-cell count. Indeed, there is evidence that in the presence of narrow CTL responses, antigenic escape mutants are likely to arise (Borrow et al. 1997; Goulder et al. 1997; Price et al. 1997) . Emergence of escape mutants can result in increased viral loads, and evolution of antigenic escape has been associated with the development of AIDS (Goulder et al. 1997 ).
Apart from the above considerations, a narrow CTL response could also arise in specialized circumstances that have not been taken into account in our models. In HTLV-I infection, a single dominant CTL response directed against the Tax protein is observed (Daenke et al. 1996) . While this could result from a CTLp response that is short-lived in the absence of antigen, another explanation is that Tax is the only antigen exposed to CTLs, and that infected cells are killed before any other viral proteins can be presented on the cell surface (C. R. M. Bangham, personal communication). In addition, the presence of speci¢c viral antigens that are highly immunogenic compared with alternative viral antigens could result in a narrow CTL response, even if it is e¤-cient and can control viral replication in the long term.
VIRUS-INDUCED IMMUNE IMPAIRMENT
Experiments with LCMV-infected mice have shown that the development of a long-lived memory CTL response requires CD4 T-cell help (Borrow et al. 1996 (Borrow et al. , 1998 Thomsen et al. 1996 Thomsen et al. , 1998 . In helper-de¢cient mice, antiviral memory CTLs go extinct following the primary response. This eventually leads to a resurgence of virus load and uncontrolled viral growth. In HIV infection, the high virus load attained during the acute phase has been shown to be associated with the absence of signi¢cant CD4 T-cell proliferative responses (Kalams et al. 1999a; Kalams & Walker 1998; Rosenberg et al. 1997 Rosenberg et al. , 1999 Rosenberg & Walker 1998) . This absence of CD4 T-cell help could result in the failure to generate memory CTLp that are long lived in the absence of antigen. According to theory, this early impairment could be the reason for persistent HIV replication and eventual loss of virus control (Wodarz & Nowak 1999b) . Our argument is supported by the observation that the HIV-speci¢c CTL response decays at a relatively fast rate following signi¢-cant drug-induced reduction of virus load (Kalams et al. 1999b) . This indicates that many of the CTLs seen in HIV-infected patients are short lived and thus do not have the capacity to control viral replication in the long term. However, it is possible that limited CD4 cell help is available, resulting in the generation of suboptimal memory CTLp, which can control viral replication for a certain period of time. Once these memory CTLp have fallen below a critical threshold, virus grows uncontrolled resulting in the development of AIDS. Variation in the duration of the asymptomatic phase of the infection might be due to di¡erences in the initial level of memory CTLp generated in the primary phase of HIV infection.
The degree of virus-induced immune impairment depends on the rate of viral replication relative to the CTL responsiveness of the host (Wodarz et al. 1998; Wodarz & Nowak 1999b ) (¢gure 4). If the viral replication rate is low relative to the CTL responsiveness, the amount of immune impairment is small. The virus is cleared, or contained at low levels in the long term. Within this parameter region, variation in the rate of viral replication results in a positive correlation between virus load and CTLs (¢gure 4). If the rate of viral replication is fast compared with the CTL responsiveness of the host, the degree of immune impairment is strong. In this parameter region, variation in the rate of viral replication results in a negative correlation between CTLs and virus load (¢gure 4). If the amount of immune impairment is still stronger, virus replication can drive the memory CTL response extinct. This can also depend on the initial conditions. Extinction of memory CTLp is promoted by low initial numbers of CD8 and CD4 T cells, as well as by a high initial virus load. Note that extinction of memory CTLp does not correspond to the complete absence of CTL in the patient, since we de¢ne memory CTLp as responses that are long lived in the absence or at low levels of antigen and depend on CD4 cell help. As discussed in the previous paragraph, many of the CTLs seen in HIV-infected patients could be short lived, unable to achieve e¤cient long-term control.
THERAPY AND LONG-TERM IMMUNOLOGICAL CONTROL
In } 4 we have shown that lack of memory CTLp, and thus lack of e¤cient immunological control, could be the result of a fast initial rate of viral replication. This prediction is supported by experimental data from macaques infected with di¡erent strains of SIV (Lifson et al. 1997) . Peak viraemia as well as post-acute viral set point were correlated with the initial rate of growth of the virus population. The level of set-point virus load in turn has been shown to correlate with the rate of disease progression (Mellors et al. 1995) . With these results in mind, therapy regimens limiting the initial growth rate of HIV could allow for the development of e¤cient CD4 T-cell responses, and consequently for the development of memory CTLp that are long lived in the absence of antigen. Such a scenario has been explored by mathematical models (Wodarz & Nowak 1999b ) (¢gure 5). The therapy regimen provides the immune system with an antigenic stimulus, while reducing the degree of immune impairment. Consequently, su¤cient levels of memory CTLp are generated, and the virus can be controlled in the absence of long-term continuous treatment (¢gure 5). Such therapy can therefore turn a potential fast progressor into a state of long-term nonprogression. Success of treatment depends on the exact timing and duration of therapy (Wodarz & Nowak 1999b) .
This treatment schedule can be modi¢ed to achieve long-term immunological control in patients who are chronically infected with HIV and are in the asymptomatic phase of the infection (Wodarz & Nowak 1999b ) (¢gure 6). In traditional treatment regimens, virus load falls to very low levels, but when drugs are withdrawn, virus load re-emerges to pre-treatment levels. In dynamical terms, withdrawal of drugs in a chronically infected patient is similar to events occurring during acute infection: the HIV population grows from low levels. According to mathematical models, a temporary drug window followed by a second phase of drug treatment can result in the development of an e¤cient memory CTL response that is long lived in the absence of antigen (¢gure 6). The drug window allows the generation of an antigenic stimulus, while reapplication of therapy prevents increased amounts of immune impairment. This results in su¤cient CD4 T-cell help to ensure the development of long-lived memory CTLp that have the capacity to control HIV in the absence of long-term continuous treatment. If the immune system is already relatively weak, repeated phases of intermittent therapy are required to progressively achieve virus control (Wodarz & Nowak 1999b ) (¢gure 7). According to mathematical models, this can be achieved even more e¤ciently by combining drug therapy with vaccination (Wodarz & Nowak 1999b ) (¢gure 7), although this approach has practical limitations at the moment (Letvin 1998).
PRE-EXPOSURE VACCINATION
These dynamics also have implications for vaccination strategies aimed at people who are uninfected but at risk of virus exposure. The e¡ectiveness of an HIV vaccine usually tends to be evaluated according to whether it can prevent infection of a signi¢cant fraction of people compared with control groups. However, the ¢ndings discussed in this paper suggest that the aim of an HIV vaccine might not so much be prevention of infection, but modulation of the dynamics so that an e¤cient, sustained CTL memory response is maintained, resulting in longterm immunological control of the virus. This notion is explained graphically in ¢gure 8. Experimental data indicate that prevention of infection might be very di¤cult to Wodarz et al. 1999b) , dependent on the presence of CD4 cell help. Hence, before therapy, the ¢gure does not show persistence of less e¤cient CTLs at higher levels, which may not control the infection in the long term and which may be maintained by continuous viral replication in HIV-infected patients. (b) Treatment regimen required to re-establish CTL memory. It consists of four phases. The ¢rst phase of treatment reduces virus load to low levels. This is followed by a drug holiday allowing the virus to replicate, thereby boosting the immune system. While virus load increases, the secondary phase of therapy is initiated. This suppresses the amount of virus-induced immune impairment and allows the establishment of CTL memory in response to the increased virus load. Finally, drug therapy can be stopped for good once CTL memory has been generated. The virus is now controlled in the long term by the immune system. Note that after the second phase of therapy virus load transiently rises and oscillates before being controlled by CTL memory. This is because during the second phase of therapy the CTL e¡ector response will have declined to low levels, allowing the virus to initially attain a positive growth rate. However, this does not indicate failure of the treatment regimen. Furthermore, it is important to point out that the secondary phase of treatment reduces virus load to lower levels in a shorter period of time than the primary phase of treatment. The reason for this is that the secondary phase of treatment is associated with a rising CTL memory response, which accelerates the death rate and consequently the decay rate of infected cells during therapy. This underlines the notion that the e¡ect of drug treatment on virus load is enhanced by the presence of an e¤cient CTL response.
achieve, since latently infected cells are generated very early in the infectious process. Prevention of infection would require that the virus does not grow at all on infection of the host. This can only be achieved if immune e¡ectors are immediately present at the time and location of infection. Typically, there is a lag phase until immune e¡ectors become activated and migrate to the site of infection, especially if infection occurs in the periphery. Hence, it might be unlikely that initial virus growth is prevented. However, vaccination could result in reduced initial virus growth, small degrees of immune impairment, maintenance of CTL memory and long-term immunological control.
CONCLUSION
The insights summarized in this review provide a theoretical framework in which to analyse the mechanisms underlying HIV-induced immune impairment, and to evaluate the potential of therapy to modulate HIV dynamics in order to achieve long-term immunological control. Improvement of our understanding requires detailed clinical investigations under carefully controlled conditions. An important experimental model is SIV infection in macaques. In this setting, treatment during acute infection has been explored systematically (Lifson et al. 1999) . The study has shown that depending on the initiation and duration of treatment during acute infection, various degrees of immunological control can be achieved in the absence of continuous therapy. Control is associated with the development of signi¢cant CD4 T-cell proliferative responses. In agreement with theory, the correlation between CD4 T-cell proliferative responses and virus load at equilibrium depended on the degree of immunological control achieved (Wodarz et al., this issue) . Animals showing e¤cient control of virus replication showed a positive correlation. Treatment in these animals While virus load is kept at low levels due to antiviral therapy, the patient is vaccinated with a cocktail of immunogenic HIV peptides. This boost induces the establishment of CTL memory while drug treatment keeps HIV-induced immune impairment to a minimum. During the generation of CTL memory, HIV load sharply drops to very low levels. This is because the CTL response is boosted in the absence of HIV replication, allowing the rising CTL to reduce virus load to ever-decreasing values. This could theoretically clear the infection. However, the presence of latently infected cells and reservoirs inaccessible to CTLs renders this goal di¤cult to achieve. Thus, when drug treatment is stopped, virus load is likely to transiently increase before being controlled in the long term by CTL memory.
might have achieved a level of control not previously observed in HIV-infected patients. On the other hand, animals showing less e¤cient virus control were characterized by a negative correlation, indicating higher degrees of immune impairment. Determinants of immunological control, as well as intermittent therapy regimens, have also been explored in HIV-infected patients. In agreement with theory, longterm non-progressors are characterized by persistent levels of CTLs despite very low levels of antigen, and by broad CTL responses directed against multiple epitopes (Harrer et al. 1996a) . Treatment during primary infection, in conjunction with intermittent therapy, has signi¢cantly modulated viral dynamics, achieving a certain degree of immunological control in a number of patients who would otherwise be faster progressors (Lisziewicz et al. 1999; Ortiz et al. 1999) . Virus control in these patients was associated with a high level and breadth of the CTL response (Ortiz et al. 1999) . This indicates the presence of signi¢cant levels of memory CTLp that are long lived in the absence of antigen (Wodarz & Nowak 1999a) . Further experimental and clinical data, in conjunction with mathematical analysis, are required to improve our understanding of these therapy regimens, in particular the relationship between timing of therapy and successful virus control.
APPENDIX A. MATHEMATICAL MODELS DISCUSSED IN THIS PAPER
(a) Basic dynamics between CD8 cells and virus replication To analyse the dynamics of antiviral CTL responses, we use the basic virus infection model taking into account uninfected (x) and infected ( y) host cells. We assume that the CTL pool consists of two populations: the precursors (w) and the e¡ectors (z). The model is given by the following set of di¡erential equations:
Target cells are produced at a rate l, die at a rate dx and become infected by virus at a rate xy. Infected cells die at a rate ay and are killed by CTL e¡ector cells at a rate pyz. On contact with antigen, CTLp proliferate at a rate cyw and di¡erentiate into e¡ector cells at a rate cq yw. CTL precursors die at a rate bw, and e¡ectors die at a rate hz. Note that we have chosen a simpli¢ed and phenomenological model of CTL memory generation, since the exact mechanisms underlying the establishment of memory are still unknown. Our conclusions are therefore independent of the exact di¡erentiation pathway of antiviral CTLs. In addition, our results are independent from the mode of CTL action. Although our models describe a lytic CTL response, mathematical models describing non-lytic antiviral e¡ector mechanisms mediated by CD8 + T cells have shown that these two pathways of CTL-mediated antiviral activity are qualitatively similar in the aspects relevant to the current analysis.
Before the host has been infected with the virus in question, the system is at the equilibrium, E0, given by
In practice, the number of virus-speci¢c CTLp in the absence of the infection, w (0) , will be greater than zero. Thus, more precisely we should write and w (0)ˆ² /b. However, as long as ² is small this represents only a small perturbation to the dynamics given by system (A1). Persistent infection of a naive host requires the basic reproductive ratio of the virus, R 0 , to be greater than unity. The basic reproductive ratio of the virus denotes the average number of infected cells produced by one infected cell at the beginning of the infection. For model (A1) it is given by R 0ˆ l/da. Subsequent virus replication may either be limited by target cell availability, or by the CTL response. Target-cell-limited virus growth is described by equilibrium (E1), given by
Correlates of CTL-mediated virus control
, z (1)ˆ0 .
If the immune system of the host is strong enough, the CTL population may expand in response to the virus infection. The condition for CTL expansion is given by c(17 q) y (1) 4 b. If this condition is ful¢lled, the system moves to equilibrium E2, given by
For low values of b, the system takes a long time to equilibrate. After an initial transient phase, the dynamics lead to a quasi-equilibrium at (ŷ), at which virus load decays only at a very small rate. Virus load at the quasiequilibrium is higher than at the true equilibrium, but has similar properties. Hence, virus load at the quasiequilibrium can be approximated byŷˆ¬y (2) , where ¬ 4 1. After a time period of 1/b, the system approaches the true equilibrium, y (2) .
(b) Multiple epitopes
The basic model can be extended to include multiple CTL clones (Iˆ1 . . . n) speci¢c for di¡erent viral epitopes of the same virus population. The model is given by the following set of di¡erential equations:
Assuming the existence of n CTL clones speci¢c for di¡erent epitopes, we can rank them according to their competitive abilities, expressed by the value of c i : c 1 4 c 2 4 c 3 4 . . . 4 c n . If y has equilibrated, w i declines with an exponential rate, described by w i (t)ˆexp(¡ b(1 ¡ c i /c 1 ))t. Only the most superior competitor survives. However, if b is small, the system takes a very long time to equilibrate. The system will remain at a quasi-equilibrium for a time-span of approximately 1/b. Virus load at the quasi-equilibrium (ŷ) has the same properties as virus load at equilibrium, but is characterized by a higher value. That is,ŷˆ¬(b/c(1 ¡ q)), where ¬ 4 1. In this case, w i declines at a rate w i (t)ˆexp(¡ b(1 ¡ (c i /c 1 )a)t). Hence, the CTL clone w i persists if c i 4 c 1 .
(c) CTL responses and immune impairment
in HIV infection Our basic model describing the dynamics of CTL responses can be adapted to HIV infection by assuming that generation of an e¡ective and sustained CTL response depends on CD4 + T-cell help, and that infection of CD4 + T cells results in impaired help. This is expressed in the following set of di¡erential equations (Wodarz et al. 1998 .
The model is derived from (A1) and assumes that the target cells for the virus are CD4 + T cells. It includes the additional feature that expansion of the CTLp population is proportional to both antigen ( y) and the number of uninfected CD4 + T cells (x) capable of delivering T-cell help.
If R 0 4 1, the system may converge to one of two equilibria. The pathogen may replicate in the absence of an e¤cient, sustained CTL response. This is described by equilibrium (E1):
, z
.
On the other hand, an e¤cient, sustained CTL response may be established and this is described by equilibrium (E2):
cq y (2) , z
where x (2) is given by a solution of a quadratic equation:
If cy (1) (x (1) 7 q) 4 b equilibrium (E1) loses stability and the system converges to equilibrium (E2), i.e. a lasting CTL response invades. If this condition is not ful¢lled equilibrium (E1) is stable. However, equilibrium (E2) may or may not be stable depending on host and viral parameters. If equilibrium (E2) is complex (‰c(l ‡ d1) ¡ b Š 2 5 4c 2 lqd) or negative (x (2) 5 q or x (2) 5 a), a persisting CTL response can never be established. On the other hand, if equilibrium (E2) is positive and real, both equilibria (E1) and (E2) are stable and the outcome depends on the initial conditions. A low initial number of CTLp, a high initial virus load, as well as a low initial CD4 + T-cell count promote the absence of an e¤cient, sustained CTL response. Overall, a high replication rate of the virus as well as a low immune responsiveness of the host shift the dynamics between HIV and the immune system in favour of the virus.
